Progress of Percutaneous Radiofrequency Catheter-Based Renal Sympathetic Denervation for Resistant Hypertension_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

 CHENZuo-guan , DIAOYong-peng ,  LIYong-jun

Department of Vascular Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China;

Corresponding author：

LIYong-jun, Email: yongj_93@hotmail.com

Keywords：

Resistant hypertension; Renal sympathetic denervation; Radiofrequency ablation

DOI：

10.7507/1007-9424.20150101

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To review the progress of percutaneous radiofrequency catheter-based renal sympathetic denervation for resistant hypertension as well as the inadequacy, and to reevaluate the clinical significance of the technology. Methods Domestic and foreign literatures were collected to summary the progress of percutaneous radiofrequency catheter-based renal sympathetic denervation in treatment of resistant hypertension. Results The percutaneous radiofrequency catheter-based renal sympathetic denervation in the treatment of resistant hypertension had obtained some positive results recently, but the long-term outcomes and safety of the technology were still subjected to further evaluation. Conclusion The effect of percutaneous radiofrequency catheter-based renal sympathetic denervation for resistant hypertension remains to be controversial, and both the equipment and technology of radiofrequency catheter-based ablation need to be improved.

Citation： CHENZuo-guan, DIAOYong-peng, LIYong-jun. Progress of Percutaneous Radiofrequency Catheter-Based Renal Sympathetic Denervation for Resistant Hypertension. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2015, 22(3): 375-379. doi: 10.7507/1007-9424.20150101 Copy

1.	Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension:analysis of worldwide data. Lancet, 2005, 365(9455):217-223.
2.	Acelajado MC, Pisoni R, Dudenbostel T, et al. Refractory hypertension:definition, prevalence, and patient characteristics. J Clin Hypertens (Greenwich), 2012, 14(1):7-12.
3.	Jin Y, Persu A, Staessen JA. Renal denervation in the management of resistant hypertension:current evidence and perspectives. Curr Opin Nephrol Hypertens, 2013, 22(5):511-518.
4.	Persell SD. Prevalence of resistant hypertension in the United States, 2003-2008. Hypertension, 2011, 57(6):1076-1080.
5.	Thorp AA, Larsen RN, Schlaich MP. Renal sympathetic nerve ablation for the management of resistant hypertension:an update. Curr Opin Nephrol Hypertens, 2013, 22(6):607-614.
6.	Geisler BP, Egan BM, Cohen JT, et al. Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension. J Am Coll Cardiol, 2012, 60(14):1271-1277.
7.	Krum H, Schlaich MP, Sobotka PA, et al. Percutaneous renal denervation in patients with treatment-resistant hypertension:final 3-year report of the Symplicity HTN-1 study. Lancet, 2014, 383(9917):622-629.
8.	Esler MD, Krum H, Schlaich M, et al. Renal sympathetic denervation for treatment of drug-resistant hypertension:one-year results from the Symplicity HTN-2 randomized, controlled trial. Circulation, 2012, 126(25):2976-2982.
9.	Bhatt DL, Kandzari DE, O'neill WW, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med, 2014, 370(15):1393-1401.
10.	Morrissey DM, Brookes VS, Cooke WT. Sympathectomy in the treatment of hypertension:review of 122 cases. Lancet, 1953, 1(6757):403-408.
11.	Williams PD, Whitbourn R. Renal sympathetic denervation:hypertension therapy and beyond. Expert Rev Med Devices, 2013, 10(3):329-338.
12.	Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension:a multicentre safety and proof-of-principle cohort study. Lancet, 2009, 373(9671):1275-1281.
13.	Schmieder RE, Redon J, Grassi G, et al. Updated ESH position paper on interventional therapy of resistant hypertension. Euro Intervention, 2013, 9 Suppl R:R58-R66.
14.	车璐, 杨宁, 李拥军. 经皮射频导管消融肾脏去交感神经支配术治疗顽固性高血压. 中国普外基础与临床杂志, 2013, 20(3):340-343.
15.	Ukena C, Mahfoud F, Kindermann I, et al. Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension. J Am Coll Cardiol, 2011, 58(11):1176-1182.
16.	Hering D, Mahfoud F, Walton AS, et al. Renal denervation in moderate to severe CKD. J Am Soc Nephrol, 2012, 23(7):1250-1257.
17.	Schmid A, Ditting T, Sobotka PA, et al. Does renal artery supply indicate treatment success of renal denervation?. Cardiovasc Intervent Radiol, 2013, 36(4):987-991.
18.	Ott C, Janka R, Schmid A, et al. Vascular and renal hemodynamic changes after renal denervation. Clin J Am Soc Nephrol, 2013, 8(7):1195-1201.
19.	Witkowski A, Prejbisz A, Florczak E, et al. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension, 2011, 58(4):559-565.
20.	Worthley SG, Tsioufis CP, Worthley MI, et al. Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension:the Enlig HTN Ⅰ trial. Eur Heart J, 2013, 34(28):2132-2140.
21.	Ormiston JA, Watson T, Van Pelt N, et al. Renal denervation for resistant hypertension using an irrigated radiofrequency balloon:12-month results from the Renal Hypertension Ablation System (RHAS) trial. Euro Intervention, 2013, 9(1):70-74.
22.	Mahfoud F, Ukena C, Schmieder RE, et al. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Circulation, 2013, 128(2):132-140.
23.	蒋雄京, 梁拓, 董徽, 等. 经导管射频消融肾交感神经治疗难治性高血压的近期疗效和安全性. 中华医学杂志, 2012, 92(46):3265-3268.
24.	Mahfoud F, Cremers B, Janker J, et al. Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension. Hypertension, 2012, 60(2):419-424.
25.	Kiuchi MG, Maia GL, de Queiroz Carreira MA, et al. Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension. Eur Heart J, 2013, 34(28):2114-2121.
26.	王丽, 卢成志, 张欣, 等. 经皮肾脏交感神经射频消融术对顽固性高血压患者肾素血管紧张系统的影响. 中华心血管病杂志, 2013, 41(1):3-7.
27.	Lenski M, Mahfoud F, Razouk A, et al. Orthostatic function after renal sympathetic denervation in patients with resistant hypertension. Int J Cardiol, 2013, 169(6):418-424.
28.	Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension:durability of blood pressure reduction out to 24 months. Hypertension, 2011, 57(5):911-917.
29.	Symplicity HTN-2 Investigators; Esler MD, Krum H, et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial):a randomised controlled trial. Lancet, 2010, 376(9756):1903-1909.
30.	Kandzari DE, Bhatt DL, Sobotka PA, et al. Catheter-based renal denervation for resistant hypertension:rationale and design of the SYMPLICITY HTN-3 Trial. Clin Cardiol, 2012, 35(9):528-535.
31.	Pokushalov E, Romanov A, Corbucci G, et al. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. J Am Coll Cardiol, 2012, 60(13):1163-1170.
32.	Benjamin MM, Fazel P, Filardo G, et al. Prevalence of and risk factors of renal artery stenosis in patients with resistant hypertension. Am J Cardiol, 2014, 113(4):687-690.
33.	Schlaich MP, Krum H, Sobotka PA, et al. Renal denervation and hypertension. Am J Hypertens, 2011, 24(6):635-642.
34.	Froeschl M, Hadziomerovic A, Ruzicka M. Percutaneous renal sympathetic denervation:2013 and beyond. Can J Cardiol, 2014, 30(1):64-74.
35.	Lenski D, Kindermann I, Lenski M, et al. Anxiety, depression, quality of life and stress in patients with resistant hypertension before and after catheter-based renal sympathetic denervation. Euro Intervention, 2013, 9(6):700-708.

1. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension:analysis of worldwide data. Lancet, 2005, 365(9455):217-223.
2. Acelajado MC, Pisoni R, Dudenbostel T, et al. Refractory hypertension:definition, prevalence, and patient characteristics. J Clin Hypertens (Greenwich), 2012, 14(1):7-12.
3. Jin Y, Persu A, Staessen JA. Renal denervation in the management of resistant hypertension:current evidence and perspectives. Curr Opin Nephrol Hypertens, 2013, 22(5):511-518.
4. Persell SD. Prevalence of resistant hypertension in the United States, 2003-2008. Hypertension, 2011, 57(6):1076-1080.
5. Thorp AA, Larsen RN, Schlaich MP. Renal sympathetic nerve ablation for the management of resistant hypertension:an update. Curr Opin Nephrol Hypertens, 2013, 22(6):607-614.
6. Geisler BP, Egan BM, Cohen JT, et al. Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension. J Am Coll Cardiol, 2012, 60(14):1271-1277.
7. Krum H, Schlaich MP, Sobotka PA, et al. Percutaneous renal denervation in patients with treatment-resistant hypertension:final 3-year report of the Symplicity HTN-1 study. Lancet, 2014, 383(9917):622-629.
8. Esler MD, Krum H, Schlaich M, et al. Renal sympathetic denervation for treatment of drug-resistant hypertension:one-year results from the Symplicity HTN-2 randomized, controlled trial. Circulation, 2012, 126(25):2976-2982.
9. Bhatt DL, Kandzari DE, O'neill WW, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med, 2014, 370(15):1393-1401.
10. Morrissey DM, Brookes VS, Cooke WT. Sympathectomy in the treatment of hypertension:review of 122 cases. Lancet, 1953, 1(6757):403-408.
11. Williams PD, Whitbourn R. Renal sympathetic denervation:hypertension therapy and beyond. Expert Rev Med Devices, 2013, 10(3):329-338.
12. Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension:a multicentre safety and proof-of-principle cohort study. Lancet, 2009, 373(9671):1275-1281.
13. Schmieder RE, Redon J, Grassi G, et al. Updated ESH position paper on interventional therapy of resistant hypertension. Euro Intervention, 2013, 9 Suppl R:R58-R66.
14. 车璐, 杨宁, 李拥军. 经皮射频导管消融肾脏去交感神经支配术治疗顽固性高血压. 中国普外基础与临床杂志, 2013, 20(3):340-343.
15. Ukena C, Mahfoud F, Kindermann I, et al. Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension. J Am Coll Cardiol, 2011, 58(11):1176-1182.
16. Hering D, Mahfoud F, Walton AS, et al. Renal denervation in moderate to severe CKD. J Am Soc Nephrol, 2012, 23(7):1250-1257.
17. Schmid A, Ditting T, Sobotka PA, et al. Does renal artery supply indicate treatment success of renal denervation?. Cardiovasc Intervent Radiol, 2013, 36(4):987-991.
18. Ott C, Janka R, Schmid A, et al. Vascular and renal hemodynamic changes after renal denervation. Clin J Am Soc Nephrol, 2013, 8(7):1195-1201.
19. Witkowski A, Prejbisz A, Florczak E, et al. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension, 2011, 58(4):559-565.
20. Worthley SG, Tsioufis CP, Worthley MI, et al. Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension:the Enlig HTN Ⅰ trial. Eur Heart J, 2013, 34(28):2132-2140.
21. Ormiston JA, Watson T, Van Pelt N, et al. Renal denervation for resistant hypertension using an irrigated radiofrequency balloon:12-month results from the Renal Hypertension Ablation System (RHAS) trial. Euro Intervention, 2013, 9(1):70-74.
22. Mahfoud F, Ukena C, Schmieder RE, et al. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Circulation, 2013, 128(2):132-140.
23. 蒋雄京, 梁拓, 董徽, 等. 经导管射频消融肾交感神经治疗难治性高血压的近期疗效和安全性. 中华医学杂志, 2012, 92(46):3265-3268.
24. Mahfoud F, Cremers B, Janker J, et al. Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension. Hypertension, 2012, 60(2):419-424.
25. Kiuchi MG, Maia GL, de Queiroz Carreira MA, et al. Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension. Eur Heart J, 2013, 34(28):2114-2121.
26. 王丽, 卢成志, 张欣, 等. 经皮肾脏交感神经射频消融术对顽固性高血压患者肾素血管紧张系统的影响. 中华心血管病杂志, 2013, 41(1):3-7.
27. Lenski M, Mahfoud F, Razouk A, et al. Orthostatic function after renal sympathetic denervation in patients with resistant hypertension. Int J Cardiol, 2013, 169(6):418-424.
28. Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension:durability of blood pressure reduction out to 24 months. Hypertension, 2011, 57(5):911-917.
29. Symplicity HTN-2 Investigators; Esler MD, Krum H, et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial):a randomised controlled trial. Lancet, 2010, 376(9756):1903-1909.
30. Kandzari DE, Bhatt DL, Sobotka PA, et al. Catheter-based renal denervation for resistant hypertension:rationale and design of the SYMPLICITY HTN-3 Trial. Clin Cardiol, 2012, 35(9):528-535.
31. Pokushalov E, Romanov A, Corbucci G, et al. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. J Am Coll Cardiol, 2012, 60(13):1163-1170.
32. Benjamin MM, Fazel P, Filardo G, et al. Prevalence of and risk factors of renal artery stenosis in patients with resistant hypertension. Am J Cardiol, 2014, 113(4):687-690.
33. Schlaich MP, Krum H, Sobotka PA, et al. Renal denervation and hypertension. Am J Hypertens, 2011, 24(6):635-642.
34. Froeschl M, Hadziomerovic A, Ruzicka M. Percutaneous renal sympathetic denervation:2013 and beyond. Can J Cardiol, 2014, 30(1):64-74.
35. Lenski D, Kindermann I, Lenski M, et al. Anxiety, depression, quality of life and stress in patients with resistant hypertension before and after catheter-based renal sympathetic denervation. Euro Intervention, 2013, 9(6):700-708.

Previous Article
脾脏硬化性血管瘤样结节性转化1例报道
Next Article
Clinical Significance of Extra-Levator Abdominoperineal Excision

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Progress of Percutaneous Radiofrequency Catheter-Based Renal Sympathetic Denervation for Resistant Hypertension

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content